View up-to-date information on Mersana Therapeutics Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
06 Aug 2022 | Mersana Therapeutics Enters into Option Agreement with GlaxoSmithKline (GSK) | Licensing Agreement |
Mersana Therapeutics Inc
|
GSK plc |
28 Feb 2022 | Mersana Therapeutics to Raise Up to USD100 Million in Public Offering of Shares | Equity Offering | - |
Mersana Therapeutics Inc |
02 Feb 2022 | Janssen Biotech Enters into Licensing Agreement with Mersana Therapeutics | Licensing Agreement |
Janssen Biotech Inc
|
Mersana Therapeutics Inc |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward